Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Interruption of progerin–lamin A/C binding ameliorates Hutchinson-Gilford progeria syndrome phenotype
Su-Jin Lee, … , Gyu Yong Song, Bum-Joon Park
Su-Jin Lee, … , Gyu Yong Song, Bum-Joon Park
Published September 12, 2016
Citation Information: J Clin Invest. 2016;126(10):3879-3893. https://doi.org/10.1172/JCI84164.
View: Text | PDF
Research Article Aging Article has an altmetric score of 8

Interruption of progerin–lamin A/C binding ameliorates Hutchinson-Gilford progeria syndrome phenotype

  • Text
  • PDF
Abstract

Hutchinson-Gilford progeria syndrome (HGPS) is a rare autosomal dominant genetic disease that is caused by a silent mutation of the LMNA gene encoding lamins A and C (lamin A/C). The G608G mutation generates a more accessible splicing donor site than does WT and produces an alternatively spliced product of LMNA called progerin, which is also expressed in normal aged cells. In this study, we determined that progerin binds directly to lamin A/C and induces profound nuclear aberrations. Given this observation, we performed a random screening of a chemical library and identified 3 compounds (JH1, JH4, and JH13) that efficiently block progerin–lamin A/C binding. These 3 chemicals, particularly JH4, alleviated nuclear deformation and reversed senescence markers characteristic of HGPS cells, including growth arrest and senescence-associated β-gal (SA–β-gal) activity. We then used microarray-based analysis to demonstrate that JH4 is able to rescue defects of cell-cycle progression in both HGPS and aged cells. Furthermore, administration of JH4 to LmnaG609G/G609G-mutant mice, which phenocopy human HGPS, resulted in a marked improvement of several progeria phenotypes and an extended lifespan. Together, these findings indicate that specific inhibitors with the ability to block pathological progerin–lamin A/C binding may represent a promising strategy for improving lifespan and health in both HGPS and normal aging.

Authors

Su-Jin Lee, Youn-Sang Jung, Min-Ho Yoon, So-mi Kang, Ah-Young Oh, Jee-Hyun Lee, So-Young Jun, Tae-Gyun Woo, Ho-Young Chun, Sang Kyum Kim, Kyu Jin Chung, Ho-Young Lee, Kyeong Lee, Guanghai Jin, Min-Kyun Na, Nam Chul Ha, Clea Bárcena, José M.P. Freije, Carlos López-Otín, Gyu Yong Song, Bum-Joon Park

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2009 Total
Citations: 1 7 11 4 7 7 6 6 4 1 54
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (54)

Title and authors Publication Year
Targeting CRM1 for Progeria Syndrome Therapy.
Soto-Ponce A, De Ita M, Castro-Obregón S, Cortez D, Landesman Y, Magaña JJ, Gonzalo S, Zavaleta T, Soberano-Nieto A, Unzueta J, Arrieta-Cruz I, Nava P, Candelario-Martínez A, García-Aguirre I, Cisneros B
Aging cell 2025
Nuclear envelope budding inhibition slows down progerin-induced aging process
Xiangyang Wang, Lin Ma, Di Lu, Gan Zhao, He Ren, Qiaoyu Lin, Mingkang Jia, Fan Huang, Shan Wang, Zhe Xu, Zhou Yang, Yan Chu, Zigang Xu, Wei Li, Li Yu, Qing Jiang, Chuanmao Zhang
Proceedings of the National Academy of Sciences of the United States of America 2024
Lamin A/C facilitates DNA damage response by modulating ATM signaling and homologous recombination pathways
Kim SJ, Park SH, Myung K, Lee KY
Animal Cells and Systems 2024
Protein isoform-centric therapeutics: expanding targets and increasing specificity.
Kjer-Hansen P, Phan TG, Weatheritt RJ
Nature reviews. Drug discovery 2024
The NLRP3 inhibitor Dapansutrile improves the therapeutic action of lonafarnib on progeroid mice
Muela\u2010Zarzuela I, Suarez\u2010Rivero JM, Boy\u2010Ruiz D, López\u2010Pérez J, Sotelo\u2010Montoro M, del Mar Navarrete\u2010Alonso M, Collado IG, Botubol\u2010Ares JM, Sanz A, Cordero MD
Aging Cell 2024
Anticancer potential of decursin, decursinol angelate, and decursinol from Angelica gigas Nakai: A comprehensive review and future therapeutic prospects
Sestito S, Ibba R, Riu F, Carpi S, Carta A, Manera C, Habtemariam S, Yeskaliyeva B, Almarhoon ZM, Sharifi\u2010Rad J, Rapposelli S
Food Science & Nutrition 2024
Decoding senescence of aging single cells at the nexus of biomaterials, microfluidics, and spatial omics
Venkataraman A, Kordic I, Li J, Zhang N, Bharadwaj NS, Fang Z, Das S, Coskun AF
NPJ Aging 2024
Targeting cellular senescence in kidney diseases and aging: A focus on mesenchymal stem cells and their paracrine factors
Hejazian SM, Hejazian SS, Mostafavi SM, Hosseiniyan SM, Montazersaheb S, Ardalan M, Zununi Vahed S, Barzegari A
Cell Communication and Signaling : CCS 2024
Tuning between Nuclear Organization and Functionality in Health and Disease
Manda NK, Golla U, Sesham K, Desai P, Joshi S, Patel S, Nalla S, Kondam S, Singh L, Dewansh D, Manda H, Rokana N
Cells 2023
Lonafarnib improves cardiovascular function and survival in a mouse model of Hutchinson-Gilford progeria syndrome
Murtada SI, Mikush N, Wang M, Ren P, Kawamura Y, Ramachandra AB, Li DS, Braddock DT, Tellides G, Gordon LB, Humphrey JD
eLife 2023
The Molecular and Cellular Basis of Hutchinson–Gilford Progeria Syndrome and Potential Treatments
Batista NJ, Desai SG, Perez AM, Finkelstein A, Radigan R, Singh M, Landman A, Drittel B, Abramov D, Ahsan M, Cornwell S, Zhang D
Genes & development 2023
Missing checkpoints in premature aging.
Xue H, Cao K
2023
Unique progerin C-terminal peptide ameliorates Hutchinson-Gilford progeria syndrome phenotype by rescuing BUBR1.
Zhang N, Hu Q, Sui T, Fu L, Zhang X, Wang Y, Zhu X, Huang B, Lu J, Li Z, Zhang Y
2023
Progerinin, an Inhibitor of Progerin, Alleviates Cardiac Abnormalities in a Model Mouse of Hutchinson-Gilford Progeria Syndrome.
Kang SM, Seo S, Song EJ, Kweon O, Jo AH, Park S, Woo TG, Kim BH, Oh GT, Park BJ
Cells 2023
The Interplay between Oxidative Stress and the Nuclear Lamina Contributes to Laminopathies and Age-Related Diseases.
Kristiani L, Kim Y
Cells 2023
[Research advances in pharmacotherapy for rare diseases in children].
Li JQ, Wang HJ
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2023
Progerin, an Aberrant Spliced Form of Lamin A, Is a Potential Therapeutic Target for HGPS
Kim BH, Chung YH, Woo TG, Kang SM, Park S, Park BJ
Cells 2023
Understanding cellular senescence: pathways involved, therapeutics and longevity aiding
Kumar A, Thirumurugan K
Cell cycle (Georgetown, Tex.) 2023
Inflammaging, cellular senescence, and cognitive aging after traumatic brain injury
Lu Y, Jarrahi A, Moore N, Bartoli M, Brann DW, Baban B, Dhandapani KM
Neurobiology of Disease 2023
Splicing Variants, Protein-Protein Interactions, and Drug Targeting in Hutchinson-Gilford Progeria Syndrome and Small Cell Lung Cancer
B Kim, T Woo, S Kang, S Park, B Park
Genes & development 2022
Crystal structure of progeria mutant S143F lamin A/C reveals increased hydrophobicity driving nuclear deformation
J Ahn, S Jeong, S Kang, I Jo, B Park, N Ha
2022
Hutchinson-Gilford Progeria Syndrome: A Literature Review
Lamis A, Siddiqui SW, Ashok T, Patni N, Fatima M, Aneef AN
Cureus 2022
Nuclear envelope morphology change upon repetitive treatment with modified antisense oligonucleotides targeting Hutchinson-Gilford Progeria Syndrome
Abdelrahman A, Nielsen MM, Stage MH, Arnspang EC
Biochemistry and Biophysics Reports 2022
Impact of Progerin Expression on Adipogenesis in Hutchinson—Gilford Progeria Skin-Derived Precursor Cells
F Najdi, P Krüger, K Djabali
Cells 2021
Preclinical Advances of Therapies for Laminopathies
L Benarroch, E Cohen, A Atalaia, RB Yaou, G Bonne, AT Bertrand
Journal of Clinical Medicine 2021
Systematic screening identifies therapeutic antisense oligonucleotides for Hutchinson–Gilford progeria syndrome
M Puttaraju, M Jackson, S Klein, A Shilo, CF Bennett, L Gordon, F Rigo, T Misteli
Nature Medicine 2021
Small-Molecule Therapeutic Perspectives for the Treatment of Progeria
J Macicior, B Marcos-Ramiro, S Ortega-Gutiérrez
International journal of molecular sciences 2021
Human WRN is an intrinsic inhibitor of progerin, abnormal splicing product of lamin A
S Kang, MH Yoon, SJ Lee, J Ahn, SA Yi, KH Nam, S Park, TG Woo, JH Cho, J Lee, NC Ha, BJ Park
Scientific Reports 2021
Isoprenylcysteine Carboxylmethyltransferase-Based Therapy for Hutchinson–Gilford Progeria Syndrome
B Marcos-Ramiro, A Gil-Ordóñez, NI Marín-Ramos, FJ Ortega-Nogales, M Balabasquer, P Gonzalo, N Khiar-Fernández, L Rolas, A Barkaway, S Nourshargh, V Andrés, M Martín-Fontecha, ML López-Rodríguez, S Ortega-Gutiérrez
ACS Central Science 2021
Progerinin, an optimized progerin-lamin A binding inhibitor, ameliorates premature senescence phenotypes of Hutchinson-Gilford progeria syndrome
S Kang, MH Yoon, J Ahn, JE Kim, SY Kim, SY Kang, J Joo, S Park, JH Cho, TG Woo, AY Oh, KJ Chung, SY An, TS Hwang, SY Lee, JS Kim, NC Ha, GY Song, BJ Park
2021
Pharmacotherapy to gene editing: potential therapeutic approaches for Hutchinson–Gilford progeria syndrome
S Saxena, S Kumar
GeroScience 2020
Mechanisms and therapeutic implications of cellular senescence in osteoarthritis
PR Coryell, BO Diekman, RF Loeser
Nature Reviews Rheumatology 2020
Nuclear lamin phosphorylation: an emerging role in gene regulation and pathogenesis of laminopathies
SY Liu, K Ikegami
Nucleus 2020
Next-generation sequencing identifies a novel heterozygous I229T mutation on LMNA associated with familial cardiac conduction disease
Y Gao, Z Han, X Wu, R Lan, X Zhang, W Shen, Y Liu, X Liu, , B Xu, W Xu
Medicine 2020
Phosphorylated Lamin A/C in the Nuclear Interior Binds Active Enhancers Associated with Abnormal Transcription in Progeria
K Ikegami, S Secchia, O Almakki, JD Lieb, IP Moskowitz
Developmental Cell 2020
Progress and trends in the development of therapies for Hutchinson–Gilford progeria syndrome
WF Lai, WT Wong
Aging Cell 2020
Mesenchymal Stem Cell-Mediated Therapy of Peripheral Artery Disease Is Stimulated by a Lamin A-Progerin Binding Inhibitor
SC Heo, YW Kwon, GT Park, SM Kwon, SS Bae, BJ Park, JH Kim
Journal of Lipid and Atherosclerosis 2020
p53 induces senescence through Lamin A/C stabilization-mediated nuclear deformation
MH Yoon, S Kang, SJ Lee, TG Woo, AY Oh, S Park, NC Ha, BJ Park
Cell Death and Disease 2019
Ca v 1.2 regulates osteogenesis of bone marrow‐derived mesenchymal stem cells via canonical Wnt pathway in age‐related osteoporosis
D Fei, Y Zhang, J Wu, H Zhang, A Liu, X He, J Wang, B Li, Q Wang, Y Jin
Aging Cell 2019
Structural basis for lamin assembly at the molecular level
J Ahn, I Jo, S Kang, S Hong, S Kim, S Jeong, YH Kim, BJ Park, NC Ha
Nature Communications 2019
Enhanced nuclear protein export in premature aging and rescue of the progeria phenotype by modulation of CRM1 activity
I GarcíaAguirre, A AlamilloIniesta, R RodríguezPérez, G VélezAguilera, E AmaroEncarnación, E JiménezGutiérrez, A VásquezLimeta, MS LaredoCisneros, SL MoralesLázaro, R TiburcioFélix, A Ortega, JJ Magaña, SJ Winder, B Cisneros
Aging Cell 2019
Senotherapeutics: emerging strategy for healthy aging and age-related disease
Kim EC, Kim JR
BMB Reports 2019
Identification of lamins as the molecular targets of LBL1 using a clickable photoaffinity probe.
Xiao X, Li BX
Methods in enzymology 2019
Methionine Restriction Extends Lifespan in Progeroid Mice and Alters Lipid and Bile Acid Metabolism
C Bárcena, PM Quirós, S Durand, P Mayoral, F Rodríguez, XM Caravia, G Mariño, C Garabaya, MT Fernández-García, G Kroemer, JM Freije, C López-Otín
Cell Reports 2018
Lamins and Lamin-Associated Proteins in Gastrointestinal Health and Disease
GF Brady, R Kwan, JB Cunha, JS Elenbaas, MB Omary
Gastroenterology 2018
An overview of treatment strategies for Hutchinson-Gilford Progeria syndrome
K Harhouri, D Frankel, C Bartoli, P Roll, AD Sandre-Giovannoli, N Lévy
Nucleus 2018
Anticancer Pyrroloquinazoline LBL1 Targets Nuclear Lamins
BX Li, J Chen, B Chao, LL David, X Xiao
ACS chemical biology 2018
HiPLA: High-throughput imaging Proximity Ligation Assay
LA Serebryannyy, T Misteli
Methods (San Diego, Calif.) 2018
Laminopathies; Mutations on single gene and various human genetic diseases
Kang SM, Yoon MH, Park BJ
BMB Reports 2018
Lamin A and microtubules collaborate to maintain nuclear morphology
Z Tariq, H Zhang, A Chia-Liu, Y Shen, Y Gete, ZM Xiong, C Tocheny, L Campanello, D Wu, W Losert, K Cao
Nucleus 2017
Intermediate filament proteins of digestive organs: physiology and pathophysiology
MB Omary
AJP Gastrointestinal and Liver Physiology 2017
Protein sequestration at the nuclear periphery as a potential regulatory mechanism in premature aging
L Serebryannyy, T Misteli
The Journal of Cell Biology 2017
A lipodystrophy-causing lamin A mutant alters conformation and epigenetic regulation of the anti-adipogenic MIR335 locus
A Oldenburg, N Briand, AL Sørensen, I Cahyani, A Shah, JØ Moskaug, P Collas
The Journal of Cell Biology 2017
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 6 X users
Referenced in 1 patents
On 3 Facebook pages
123 readers on Mendeley
See more details